Lactobacillus delbrueckii subsp. bulgaricus – LDB01 (DSM 16606)
Rebalance of intestinal microbiota
Lactobacillus delbrueckii subsp. bulgaricus – LDB01 (DSM 16606) Read More »
Adults
Lactobacillus delbrueckii subsp. delbrueckii – LDD01 (DSM 22106)
Gaseous colic • Inhibition of E. coli, including toxinogenic O157:H7 • Inhibition of Klebsiella pneumoniae and of different coliforms isolated from colicky infants • Inhibition of pathogens E. coli, Klebsiella and gas-producing coliforms
Lactobacillus delbrueckii subsp. delbrueckii – LDD01 (DSM 22106) Read More »
Lactobacillus fermentum – LF09 (DSM 18298)
Inhibition of pathogenic Candida species • Restoration of a physiological gut barrier • Inhibition of Candida growth • Strain from brushing of the gut mucosa
Lactobacillus fermentum – LF09 (DSM 18298) Read More »
Lactobacillus fermentum – LF11 (DSM 19188)
Inhibition of pathogenic Candida species • Vaginal health • Inhibition of Candida strains • Counteraction of vulvovaginal candidiasis (VVC)
Lactobacillus fermentum – LF11 (DSM 19188) Read More »
Lactobacillus fermentum – ME-3 (DSM 14241)
Under license from the University of Tartu for food applications Cardiovascular health • LDL-cholesterol lowering • Antioxidant properties
Lactobacillus fermentum – ME-3 (DSM 14241) Read More »
Lactobacillus gasseri – LGS06 (DSM 32405)
Weight management • Vaginal health • Rebalance of a healthy vaginal microbiota
Lactobacillus gasseri – LGS06 (DSM 32405) Read More »
Lactobacillus paracasei – LPC09 (DSM 24243)
Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus paracasei – LPC09 (DSM 24243) Read More »
Lactobacillus plantarum – LP01 (LMG P-21021)
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus plantarum – LP01 (LMG P-21021) Read More »
Lactobacillus plantarum – LP02 (LMG P-21020)
Cystitis • Inhibition of E. coli
Lactobacillus plantarum – LP02 (LMG P-21020) Read More »
Lactobacillus plantarum – LP09 (DSM 25710)
Anti-pathogen activity
Lactobacillus plantarum – LP09 (DSM 25710) Read More »
Lactobacillus reuteri – LRE02 (DSM 23878)
Production of reuterin and vitamin B12 • Anti-pathogen activity and immunostimulation (induction of IFN-gamma) • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus reuteri – LRE02 (DSM 23878) Read More »
Lactobacillus reuteri – LRE03 (DSM 22106)
Production of reuterin • Immunostimulation with induction of IFN-γ
Lactobacillus reuteri – LRE03 (DSM 22106) Read More »
Lactobacillus rhamnosus – GG (ATCC 53103)
Diarrhea • Rotaviral diarrhea • Gastroenteritis Also available as Active Pharmaceutical Ingredient (API) Autism and ADH prevention • Oral health • Caries prevention • Inhibition of Streptococcus mutans
Lactobacillus rhamnosus – GG (ATCC 53103) Read More »
Lactobacillus rhamnosus – LR04 (DSM 16605)
Diarrhea • Inhibition of E. coli, including enterohemorrhagic O157:H7 • Cystitis • Inhibition of E. coli
Lactobacillus rhamnosus – LR04 (DSM 16605) Read More »
Lactobacillus rhamnosus – LR06 (DSM 21981)
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus rhamnosus – LR06 (DSM 21981) Read More »
Lactobacillus salivarius – CRL1328
Inhibition of Enterococcus faecalis, Enterococcus faecium and Neisseria gonorrhoeae • Vaginal health • Prevention of urogenital infections • Inhibition of Candida
Lactobacillus salivarius – CRL1328 Read More »
Lactobacillus salivarius – LS01 (DSM 22775)
Treatment of atopic dermatitis • Improvement of the Quality of Life in subjects with Atopic Dermatitis • Skin health • Inhibition of C. acnes (formerly classified as P. acnes) – induced IL-8 release. Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus salivarius – LS01 (DSM 22775) Read More »
Lactobacillus salivarius – LS03 (DSM 22776)
Acne – Anti-pathogen activity: inhibition of C. acnes (formerly classified as P. acnes) and its induction of IL-8 • Immunomodulation • Strong adhesion to the intestinal mucosa
Lactobacillus salivarius – LS03 (DSM 22776) Read More »
Streptococcus thermophilus – YO8 (DSM 17843)
Rebalance of intestinal microbiota
Streptococcus thermophilus – YO8 (DSM 17843) Read More »
Streptococcus thermophilus – ST10 (DSM 25246)
Daily dosage in clinical study: 1 billion CFU
Streptococcus thermophilus – ST10 (DSM 25246) Read More »
Lactobacillus salivarius I 1794
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at
Lactobacillus salivarius I 1794 Read More »
Lactobacillus paracasei P 30020
Recurrent cystitis. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 30020. Isolated from goat’s milk. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf life raw material: 12 months when stored below 8°C.
Lactobacillus paracasei P 30020 Read More »
Lactobacillus paracasei I 1688
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at
Lactobacillus paracasei I 1688 Read More »
Lactobacillus paracasei I 1687
Immunomodulatory activity. Deposited at the International Culture Collection CNCM – Institute Pasteur (Paris). Deposit N°CNCM I 1687. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf-life raw material: 12 months when stored below -20°C or 6 months when stored
Lactobacillus paracasei I 1687 Read More »
Lactobacillus plantarum CVI15B
Immunomodulatory activity. Deposited at the International Culture Collection CNCM – Institute Pasteur (Paris). Deposit N°LMG P 30023 Isolated from a cabbage. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf-life raw material: 12 months when stored below -20°C or 6 months when stored below
Lactobacillus plantarum CVI15B Read More »
Lactobacillus rhamnosus ATCC-53103
Immunomodulatory activity. Anti-inflammatory activity. Deposited at the American Type Culture Collection ATCC-53103. Deposit N°ATCC-53103. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf-life raw material: 12 months when stored below 8°C. Also available as Active Pharmaceutical Product (API)
Lactobacillus rhamnosus ATCC-53103 Read More »
Lactobacillus delbrueckii P 18805
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. They are deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18805. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural
Lactobacillus delbrueckii P 18805 Read More »
Lactobacillus crispatus P 17631
Treatment of skin manifestations associated with Malassezia spp. such as seborrheic dermatitis and pityriasis versicolor, caused by an imbalance of the skin microbiota. OILY SUSPENSION Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 17631. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural
Lactobacillus crispatus P 17631 Read More »
Lactobacillus acidophilus P 18806
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18806. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG
Lactobacillus acidophilus P 18806 Read More »
Streptococcus thermophilus P 18807
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18807. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG
Streptococcus thermophilus P 18807 Read More »
Lactobacillus paracasei LC18
Balance of the intestinal flora. It helps the normal function of the neuron system and psychological function. It also contributes to the normal cognitive function. L. plantarum LM2 and L. brevis Y1 produce, respectively, Acetylcholine (Ach) and Gamma-aminobutyric acid (GABA), inhibitory neurotransmitter. It has an immunomodulating action, it helps reinforce the body’s natural defenses and
Lactobacillus paracasei LC18 Read More »
Lactobacillus brevis Y1
Balance of the intestinal flora. It helps the normal function of the neuron system and psychological function. It also contributes to the normal cognitive function. L. plantarum LM2 and L. brevis Y1 produce, respectively, Acetylcholine (Ach) and Gamma-aminobutyric acid (GABA), inhibitory neurotransmitter. It has an immunomodulating action, it helps reinforce the body’s natural defenses and
Lactobacillus brevis Y1 Read More »
Lactobacillus plantarum LM2
Balance of the intestinal flora. It helps the normal function of the neuron system and psychological function. It also contributes to the normal cognitive function. L. plantarum LM2 and L. brevis Y1 produce, respectively, Acetylcholine (Ach) and Gamma-aminobutyric acid (GABA), inhibitory neurotransmitter. It has an immunomodulating action, it helps reinforce the body’s natural defenses and
Lactobacillus plantarum LM2 Read More »
Lacticaseibacillus rhamnosus HA-114
L. rhamnosus HA-114 is an innovative patent-pending probiotic strain able to improve eating and mood-related behaviors in overweight adults undergoing a diet-induced weight loss. It could favor wellness and facilitate adherence during a diet-based weight reduction program, through its action on the brain-gut axis. L. rhamnosus HA-114 supports weight management efforts during a diet (eating
Lacticaseibacillus rhamnosus HA-114 Read More »
Lactobacillus helveticus Lafti® L10
L. helveticus Lafti® L10 has been documented on athletes’ population specifically to answer their needs in immune health. Sport induces a physiological stress and can significantly impair natural defenses. Lafti® L10 helps over trained athletes to recover an effective immune system similar to healthy athletes by increasing IFN-γ levels, a biomarker for natural defenses (p=0.01) as
Lactobacillus helveticus Lafti® L10 Read More »
Bifidobacterium lactis Lafti® B94
The probiotic strain Bifidobacterium lactis Lafti® B94 has been specifically documented in the area of gut health. It benefits from a strong body of clinical evidence, supported by in vitro and in vivo documentation of its modes of action. A converging body of clinical evidence: digestive comfort Gut transit in all population groups (infants from birth, children, adolescents, adults): Bifidobacterium animalis
Bifidobacterium lactis Lafti® B94 Read More »
Hafnia alvei HA4597
Hafnia alvei is the first precision probiotic developed based on a target-based approach and a screening for strains producing ClpB, a protein mimicking alpha-MSH and activating the signals of satiety. Its mechanism of action and demonstration in efficacy in mice and humans make it a uniquely positioned, innovative next-gen probiotic for weight management.
Hafnia alvei HA4597 Read More »
Lactiplantibacillus plantarum WJL
L. plantarum WJL is a second precision probiotic developed by TargEDys in collaboration with the Functional Genomics Institute of Lyon, selected by its ability to optimize the amino acid absorption, by a stimulation of the somatotroic axis. The potenital of this strain is large: from children growth, elderly bones and muscle mass, sport nutrition to
Lactiplantibacillus plantarum WJL Read More »
Lactiplantibacillus plantarum 299v (LP299V®) (DSM 9843)
Lactiplantibacillus plantarum 299v (LP299V®) is the most clinically documented L. plantarum strain in the world. LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within
Lactiplantibacillus plantarum 299v (LP299V®) (DSM 9843) Read More »
